Area of research
Cardiology and Cardiovascular Medicine · Infectious Diseases
Research interest
Research interests include Medicine, Placebo, Vaccination, Adverse effect, Tolerability, and Enterovirus 71.
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials
Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial